INTERHEART Risk Score — Assess Your Myocardial Infarction Risk
The INTERHEART Risk Score is derived from the landmark INTERHEART study, a global case-control study that identified nine modifiable risk factors accounting for over 90% of the population-attributable risk of myocardial infarction worldwide.
About
The INTERHEART Risk Score originates from the INTERHEART study, a standardized international case-control study published in The Lancet in 2004 by Yusuf et al. The study enrolled 29,972 participants (15,152 cases with first acute MI and 14,820 controls with no history of heart disease) from 262 centers across 52 countries representing every inhabited continent. The study identified nine potentially modifiable risk factors that collectively accounted for over 90% of the population-attributable risk of acute myocardial infarction. These risk factors, ranked by odds ratio, are: ApoB/ApoA1 ratio (OR 3.25 for top vs bottom tertile), smoking (OR 2.87 for current smokers), psychosocial stress (OR 2.67), diabetes (OR 2.37), hypertension (OR 1.91), abdominal obesity (OR 1.62, defined by waist-to-hip ratio >0.85 for women and >0.90 for men), and protective factors including daily fruit and vegetable consumption (OR 0.70), regular physical activity (OR 0.86), and regular alcohol consumption (OR 0.91). The INTERHEART study demonstrated a remarkable consistency of risk factor effects across all geographic regions and ethnic groups, supporting a common causal pathway for myocardial infarction irrespective of nationality or socioeconomic status. The study's strength lies in its enormous sample size, standardized methodology across centers, and adjustment for confounding variables. The findings revolutionized the understanding of MI prevention by showing that modifying these nine factors could potentially prevent the vast majority of premature myocardial infarctions globally.
Formula
Total Risk Factors Present / 9 — Each factor contributes 1 point. Score 0-9.
The INTERHEART risk score is calculated by summing nine binary (yes/no) risk factors, each contributing 1 point when present. The nine factors are: smoking, diabetes, hypertension, abdominal obesity (waist-to-hip ratio >0.85 for women, >0.90 for men), elevated ApoB/ApoA1 ratio, psychosocial stress, low daily fruit and vegetable intake, lack of regular physical activity, and no regular alcohol consumption. Total score ranges from 0 to 9. Interpretation: 0-2 points = low risk (few modifiable risk factors present), 3-5 points = moderate risk (several risk factors present requiring lifestyle intervention), 6-9 points = high risk (multiple risk factors present, urgent comprehensive prevention needed). While the original INTERHEARTo study used odds ratios for individual risk factors rather than a simple additive score, this simplified scoring system provides a practical clinical tool for patient education and risk communication.
Score Interpretation
The INTERHEART study represents one of the most important epidemiological contributions to cardiovascular prevention in the 21st century. Its central finding — that nine simple, modifiable risk factors account for over 90% of the population-attributable risk of acute myocardial infarction — has profound implications for global public health policy and clinical practice. The study's striking finding that these risk factors operate consistently across all geographic regions, ethnic groups, and socioeconomic strata supports a universal approach to cardiovascular prevention that transcends national boundaries. Clinically, the INTERHEART findings highlight the importance of comprehensive risk factor modification rather than single-risk-factor approaches. The ApoB/ApoA1 ratio emerged as the strongest independent risk factor, underscoring the critical role of apolipoprotein assessment in cardiovascular risk stratification. The study also drew attention to psychosocial stress as a significant and often overlooked risk factor for MI, validating clinical observations linking chronic stress, depression, and social isolation to cardiovascular events. The protective associations of daily fruit and vegetable consumption, regular physical activity, and moderate alcohol intake reinforce the importance of lifestyle-based prevention strategies. From a population health perspective, the INTERHEART study provides a compelling rationale for investments in tobacco control, healthy food policies, urban design for physical activity, and workplace stress reduction programs. The findings have been incorporated into global cardiovascular prevention guidelines, including the World Heart Federation roadmaps and WHO global action plans for non-communicable disease prevention. At the individual patient level, the INTERHEART risk factors serve as a practical checklist for clinicians to assess and address modifiable cardiovascular risk during routine consultations.
Low Risk (0-2) — 0–2
Few modifiable risk factors present. Low estimated risk of MI.
Management: Continue healthy lifestyle habits. Maintain regular physical activity and balanced diet. Reassess risk factors periodically.
Moderate Risk (3-5) — 3–5
Several modifiable risk factors present. Moderate estimated risk of MI.
Management: Target lifestyle modification for each risk factor present. Consider pharmacotherapy for hypertension, diabetes, or dyslipidemia as needed. Increase physical activity to 30 min/day. Dietary counseling. Screen for CVD risk factors.
High Risk (6-9) — 6+
Multiple modifiable risk factors present. High estimated risk of MI.
Management: Comprehensive cardiovascular risk assessment. Urgent lifestyle intervention. Optimize pharmacotherapy for all modifiable risk factors. Consider cardiology referral. Screen for target organ damage.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Adults aged 35-70 without known CVD | 0-9 points | Low: 0-2, Moderate: 3-5, High: 6-9 |
Dr. Khaled Hassan
Dr. Khaled is a cardiology consultant with 20 years of experience in managing cardiovascular patients.
View medical review board & editorial policy →Example Calculation
A 52-year-old man from Riyadh, Saudi Arabia, presents for a routine health evaluation. He has a 30-pack-year smoking history and currently smokes 20 cigarettes/day. He was diagnosed with type 2 diabetes three years ago and takes metformin 1000 mg daily (HbA1c 7.8%). He has hypertension treated with amlodipine 5 mg daily (BP 138/86 mmHg). His waist circumference is 106 cm and hip circumference 98 cm, giving a waist-to-hip ratio of 1.08 (>0.90, indicating abdominal obesity). He works as a senior executive and reports high levels of work-related stress with poor sleep quality. His diet includes fruits or vegetables only 2-3 times per week. He does not engage in any regular exercise. He does not consume alcohol due to religious beliefs. His recent lipid profile shows total cholesterol 220 mg/dL, HDL 38 mg/dL, LDL 155 mg/dL, and triglycerides 185 mg/dL. His physician recently ordered apolipoprotein testing showing ApoB 120 mg/dL and ApoA1 115 mg/dL, giving an ApoB/ApoA1 ratio of 1.04 (elevated). INTERHEART Risk Score: Smoking (1), Diabetes (1), Hypertension (1), Abdominal Obesity (1), High ApoB/ApoA1 (1), Psychosocial Stress (1), Low Fruit/Vegetable Intake (1), Low Exercise (1), No Alcohol (1). Total: 9/9 — High Risk. Clinical interpretation: This patient has all nine modifiable risk factors present, placing him at the maximum INTERHEART risk category. He requires urgent comprehensive cardiovascular prevention including smoking cessation program (nicotine replacement therapy + counseling), optimization of diabetes control (consider adding SGLT2 inhibitor or GLP-1 receptor agonist), intensification of antihypertensive therapy (target BP <130/80 mmHg), high-intensity statin (atorvastatin 40-80 mg), dietary counseling for Mediterranean diet, structured exercise prescription, stress management techniques, and referral to preventive cardiology.
Related Conditions
Related Medications
Common Mistakes
Treating the INTERHEART score as a diagnostic tool for acute MI
The INTERHEART score is a risk assessment tool that estimates the presence of potentially modifiable risk factors for MI, not a diagnostic test for acute coronary syndrome. Patients presenting with chest pain or other symptoms of ACS require immediate clinical evaluation, ECG, and cardiac biomarkers regardless of their risk score.
Assuming all risk factors carry equal weight in predicting MI
While the simplified score assigns 1 point per risk factor, the original INTERHEART study found substantial differences in odds ratios. ApoB/ApoA1 ratio (OR 3.25) and smoking (OR 2.87) carry significantly higher risk than low fruit/vegetable intake (OR 0.70) or no alcohol (OR 0.91). The simplified score is a communication tool; individual risk factors should be addressed with appropriate intensity.
Using the INTERHEART score in patients with established coronary artery disease
The INTERHEART score was derived from patients presenting with first acute MI compared to healthy controls. Patients with established CAD are already at high risk and require secondary prevention strategies irrespective of their current risk factor profile. The score is most appropriate for primary prevention risk communication.
Neglecting the psychosocial stress domain
Psychosocial stress was found to be the third strongest risk factor in the INTERHEART study (OR 2.67), yet it is often overlooked in clinical practice. Clinicians should systematically assess for stress, depression, anxiety, and life event burden as part of comprehensive cardiovascular risk assessment.
Frequently Asked Questions
What was the INTERHEART study?
How is INTERHEART different from Framingham or ASCVD risk scores?
Can the INTERHEART score be used to guide treatment decisions?
Does the INTERHEART score apply to all populations?
What is the ApoB/ApoA1 ratio and why is it important?
References
- Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952. PubMed
- Yusuf S, Hawken S, Ôunpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640-1649. PubMed
- Rosengren A, Hawken S, Ôunpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):953-962. PubMed
- McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008;372(9634):224-233. PubMed
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596-e646. PubMed